This inventor holds 1 USPTO granted patent. Top assignee: University of South Florida. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Glenn Roma: Innovator in Antibacterial Research
Introduction
Glenn Roma is a notable inventor based in Tampa, Florida, recognized for his contributions to the field of antibacterial research. His work focuses on developing new derivatives of ciprofloxacin, a widely used antibiotic, to combat infections caused by facultative intracellular bacteria.
Latest Patents
Glenn Roma holds a patent for the "Activity of new N-acylated ciprofloxacin derivatives against facultative intracellular bacteria." This patent highlights the potential of N-acyl ciprofloxacin analogues, which have been chemically synthesized and tested in vitro for their effectiveness against various pathogenic species. The research involved testing nine strains of bacteria, including five of one type, two of another, and one each of others, for susceptibility to different N-acyl ciprofloxacin derivatives. Seven of these derivatives, labeled RC4-125, RC4-143, RC4-147, RC5-28, RC5-29, RC5-32, and RC5-69, demonstrated significant intracellular antibacterial activity. These synthetically derived compounds may offer new therapeutic options for treating infections.
Career Highlights
Glenn Roma is affiliated with the University of South Florida, where he conducts his research and development work. His innovative approach to antibiotic development has positioned him as a key figure in the fight against bacterial infections.
Collaborations
Glenn has collaborated with esteemed colleagues, including Edward Turos and Burt E. Anderson, to advance his research and explore the therapeutic potential of his inventions.
Conclusion
Glenn Roma's work in developing N-acyl ciprofloxacin derivatives represents a significant advancement in antibacterial research. His contributions may lead to improved treatment options for infections caused by challenging bacterial pathogens.